Skip to content
  1. Home
  2. Latest news
  3. Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions
David Westin and Johnson & Johnson Chairman and CEO Alex Gorsky Sat Down for An Interview for Bloomberg Big Decisions
David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions

See what Alex Gorsky had to say about his goal to help change the trajectory of health for humanity—and how he believes the U.S. healthcare system must change for the better.

David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

What do serving in the military and overseeing the world’s largest healthcare company have in common?

Both require that you earn the right to lead and fulfill your duty to those you serve—whether that’s your country or the patients, consumers, employees and stockholders you represent, says Johnson & Johnson Chairman and CEO Alex Gorsky, who served as a captain in the U.S. Army.

That’s just one of the insights he revealed last week during an interview with David Westin of Bloomberg Big Decisions that was filmed at the company’s new museum, where he answered tough questions on transparency in drug pricing and affordable healthcare—and explained why his biggest legacy will be to live up to Johnson & Johnson’s historic company code of conduct, the Credo.

Watch the full interview here on Bloomberg.com.


More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.